M. Okada

1.6k total citations · 1 hit paper
51 papers, 1.3k citations indexed

About

M. Okada is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, M. Okada has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 5 papers in Oncology. Recurrent topics in M. Okada's work include Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (7 papers) and Pleural and Pulmonary Diseases (6 papers). M. Okada is often cited by papers focused on Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (7 papers) and Pleural and Pulmonary Diseases (6 papers). M. Okada collaborates with scholars based in Japan, United States and United Kingdom. M. Okada's co-authors include Wataru Nishijima, Aloysius U. Baes, Masahiro Tsuboi, Hisao Asamura, Hirohito Tada, Kenichi Nakamura, Tatsuhiro Shibata, Shinichiro Nakamura, Hisashi Saji and R. Nakajima and has published in prestigious journals such as Water Research, Journal of Cleaner Production and Chemosphere.

In The Last Decade

M. Okada

46 papers receiving 1.2k citations

Hit Papers

A Phase III Randomized Trial of Lobectomy Versus Limited ... 2009 2026 2014 2020 2009 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Okada Japan 15 627 204 202 146 120 51 1.3k
Erica Hoffer Israel 15 47 0.1× 261 1.3× 41 0.2× 43 0.3× 118 1.0× 46 896
Wenjuan Jiang China 17 212 0.3× 82 0.4× 25 0.1× 23 0.2× 66 0.6× 45 935
Thomas McDonald United States 18 123 0.2× 70 0.3× 61 0.3× 40 0.3× 22 0.2× 29 2.0k
Sujing Liu China 19 106 0.2× 97 0.5× 20 0.1× 18 0.1× 104 0.9× 46 1.2k
Seung Hoon Song South Korea 13 328 0.5× 55 0.3× 12 0.1× 24 0.2× 260 2.2× 24 1.0k
Sylwia Męczyńska‐Wielgosz Poland 19 96 0.2× 54 0.3× 160 0.8× 17 0.1× 31 0.3× 36 1.1k
Yongxin Zheng China 19 69 0.1× 153 0.8× 39 0.2× 31 0.2× 49 0.4× 62 1.2k
Huan Xiao China 13 52 0.1× 139 0.7× 33 0.2× 46 0.3× 56 0.5× 58 817
Chunyang Jiang China 23 119 0.2× 191 0.9× 22 0.1× 6 0.0× 61 0.5× 52 1.6k
Lulin Ma China 16 130 0.2× 75 0.4× 23 0.1× 100 0.7× 75 0.6× 60 724

Countries citing papers authored by M. Okada

Since Specialization
Citations

This map shows the geographic impact of M. Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Okada more than expected).

Fields of papers citing papers by M. Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Okada. The network helps show where M. Okada may publish in the future.

Co-authorship network of co-authors of M. Okada

This figure shows the co-authorship network connecting the top 25 collaborators of M. Okada. A scholar is included among the top collaborators of M. Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Okada. M. Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goto, Yoshihito, Yuichi Sakairi, Hidemi Suzuki, et al.. (2024). 1208MO Phase III trial of perioperative pirfenidone therapy for lung cancer with idiopathic pulmonary fibrosis (IPF): NEJ034 study. Annals of Oncology. 35. S776–S776.
2.
Hayashi, Hidetoshi, M. Okada, Takashi Kijima, et al.. (2020). 1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma. Annals of Oncology. 31. S1076–S1076. 2 indexed citations
3.
Tsutani, Yasuhiro, et al.. (2018). P2.01-97 Prognostic Factors in Resected Lung Mucinous Adenocarcinoma: Clinical and Pathological Features. Journal of Thoracic Oncology. 13(10). S702–S702. 2 indexed citations
4.
Nakano, Takashi, M. Okada, Takashi Kijima, et al.. (2018). OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study). Journal of Thoracic Oncology. 13(10). S338–S338. 6 indexed citations
5.
Ito, Masaoki, Carles Codony, Jordi Codony‐Servat, et al.. (2018). 25P A non-pathway-specific approach in EGFR and KRAS mutant or squamous cell histology non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 13(4). S13–S14.
6.
Yoshiya, Tomoharu, Masaoki Ito, Keizo Misumi, et al.. (2016). The effect of rikkunshito, a traditional Japanese herbal medicine, on food intake and plasma acylated ghrelin levels in lung cancer patients treated with platinum-based chemotherapy. Annals of Oncology. 27. vi510–vi510. 5 indexed citations
7.
Tsutani, Yasuhiro, Teruhisa Takuwa, Yoshihiro Miyata, et al.. (2012). Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma. Annals of Oncology. 24(4). 1005–1010. 16 indexed citations
8.
Tsutani, Yasuhiro, Yugo Yamashita, Keizo Misumi, et al.. (2012). Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid. European Journal of Cardio-Thoracic Surgery. 42(5). e96–e101. 5 indexed citations
9.
Okada, M., Yasuhiro Tsutani, Toshiyuki Ikeda, et al.. (2011). Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer. Interactive Cardiovascular and Thoracic Surgery. 14(1). 5–11. 46 indexed citations
10.
Nakamura, Kenichi, Hisashi Saji, R. Nakajima, et al.. (2009). A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L). Japanese Journal of Clinical Oncology. 40(3). 271–274. 400 indexed citations breakdown →
11.
Takakura, Yoshinori, et al.. (2009). Short disease‐free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer. Colorectal Disease. 12(7Online). e68–75. 30 indexed citations
13.
Katayama, Yoko, et al.. (2003). The characteristics of the bacterial community structure and population dynamics for phosphorus removal in SBR activated sludge processes. Water Research. 37(12). 2944–2952. 25 indexed citations
14.
Okada, M., et al.. (2001). Multiple Venous Aneurysm of a Basilic Vein. Annals of Vascular Surgery. 15(4). 485–487. 12 indexed citations
15.
Kondo, Katsuhiko, et al.. (2000). Dynamics of medicinal plants in Japan estimated by the herbarium specimens.. 75(6). 347–359. 3 indexed citations
16.
Sakakibara, Iwao, Susumu Terabayashi, Masayoshi Kubo, et al.. (1999). Effect on locomotion of indole alkaloids from the hooks of Uncaria plants. Phytomedicine. 6(3). 163–168. 52 indexed citations
17.
Sakakibara, Iwao, Susumu Terabayashi, Masayoshi Kubo, et al.. (1998). Effect of oxindole alkaloids from the hooks of Uncaria macrophylla on thiopental-induced hypnosis. Phytomedicine. 5(2). 83–86. 33 indexed citations
18.
Amagaya, Sakae, Atsushi Ishige, Shuichi Takeda, et al.. (1998). General pharmacological properties of TJ-9 extract. Phytomedicine. 5(3). 165–175. 1 indexed citations
19.
Okada, M., et al.. (1997). Studies on Aromatase Inhibitors IV. Synthesis and Biological Evaluation of N,N-Disubstituted-5-aminopyrimidine Derivatives.. Chemical and Pharmaceutical Bulletin. 45(8). 1293–1299. 8 indexed citations
20.
Ota, Takeyoshi, et al.. (1994). Effect of Mitral Valve Surgery on Severely Impaired Pulmonary Function. The Thoracic and Cardiovascular Surgeon. 42(2). 94–102. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026